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The emergence of multidrug-resistant (MDR) Klebsiella pneumoniae has resulted in a more frequent reliance on treatment us-
ing colistin. However, resistance to colistin (Colr) is increasingly reported from clinical settings. The genetic mechanisms that
lead to Colr in K. pneumoniae are not fully characterized. Using a combination of genome sequencing and transcriptional profil-
ing by RNA sequencing (RNA-Seq) analysis, distinct genetic mechanisms were found among nine Colr clinical isolates. Colr was
related to mutations in three different genes in K. pneumoniae strains, with distinct impacts on gene expression. Upregulation of
the pmrH operon encoding 4-amino-4-deoxy-L-arabinose (Ara4N) modification of lipid A was found in all Colr strains. Altera-
tion of the mgrB gene was observed in six strains. One strain had a mutation in phoQ. Common among these seven strains was
elevated expression of phoPQ and unaltered expression of pmrCAB, which is involved in phosphoethanolamine addition to lipo-
polysaccharide (LPS). In two strains, separate mutations were found in a previously uncharacterized histidine kinase gene that is
part of a two-component regulatory system (TCRS) now designated crrAB. In these strains, expression of pmrCAB, crrAB, and an
adjacent glycosyltransferase gene, but not that of phoPQ, was elevated. Complementation with the wild-type allele restored colis-
tin susceptibility in both strains. The crrAB genes are present in most K. pneumoniae genomes, but not in Escherichia coli. Addi-
tional upregulated genes in all strains include those involved in cation transport and maintenance of membrane integrity. Be-
cause the crrAB genes are present in only some strains, Colr mechanisms may be dependent on the genetic background.
The increasing occurrence of multidrug-resistant (MDR) Kleb-siella pneumoniae has expanded reliance on last-line therapies
like colistin, a cationic antimicrobial peptide, for effective treat-
ment (1). Of concern is the growing recovery of colistin-resistant
(Colr) strains from clinical settings (2–4). Colistin disrupts mem-
brane integrity through displacement of cations like Mg2 and
Ca2 in the outer membrane, leading to cell lysis (5). Resistance
mechanisms described to date involve lipopolysaccharide (LPS)
modification, particularly through derivatization of lipid A phos-
phate moieties with a sugar or ethanolamine. These modifications
reduce the electrostatic affinity between the cationic colistin and
anionic LPS. Mutations in the transcriptional regulatory sys-
tems controlling these LPS modifications are a common ge-
netic mechanism leading to colistin resistance. For example,
the PhoPQ and PmrAB two-component regulatory systems
(TCRS) regulate expression of the gene (pmrC) that codes for
the addition of phosphoethanolamine (pETN) and genes en-
coding biosynthesis and lipid A transfer of 4-amino-4-deoxy-
L-arabinose (Ara4N) (pmrHFIJKLM) (Fig. 1A). Other regula-
tory components in this pathway include PmrD and MgrB, two
connector proteins that convey feedback between the PmrAB and
PhoPQ TCRS (6–9) (Fig. 1A). Mutations in pmrAB, phoPQ, and
mgrB have been identified as mechanisms conferring Colr in sev-
eral Gram-negative pathogens, including K. pneumoniae (10–15).
How colistin resistance mechanisms alter the global transcrip-
tion profile and how transcriptome profiles vary in the genetic
mechanism(s) that confers colistin resistance remain to be exam-
ined. By coupling complete genome sequence data and whole-
genome transcriptional characterization of colistin-susceptible
(Cols) and Colr K. pneumoniae, we were able to relate genetic
mechanisms of colistin resistance to gene expression changes.
MATERIALS AND METHODS
Strains and genomic analyses. Strains originated from a collection of
KPC-producing K. pneumoniae isolates obtained from a consortium of
tertiary-care hospitals previously described (16, 17). Colistin MICs were
determined with a Sensititre system (17) and confirmed by Etest strips
(bioMérieux). Genome sequencing was previously described (17) and
consisted of Illumina HiSeq reads assembled with Newbler and annotated
using the Comprehensive Microbial Resource annotation pipeline (18).
Genome sequences were compared using Mauve (19), and gene content
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analysis used PanOCT (20). Single-nucleotide variants (SNVs) were de-
termined using BWA for sequence read mapping (21) and Mpileup (22)
for SNV detection in paired and closely related strains. A SNV-based
phylogeny was constructed from kSNP software (23) output, as described
in reference 17, with the inclusion of additional non-ST258 reference
genomes. Two strains had paired isogenic Cols isolates (UHKPC57 with
UHKPC179, and UHKPC27 with UHKPC52). SNVs were associated with
Colr based on their presence in one of the Colr strains (Table 1) and the
absence of that allele in all 48 Cols strains from reference 17 and additional
genomes of the same MLST type in GenBank.
RNA-Seq experiments. The 57 strains characterized in reference 17
were grown to mid-log phase at 37°C in LB broth. Cells were harvested
and preserved with RNAprotect (Qiagen) until extraction with Ultra-
Clean RNA isolation kits (MoBio). cDNA libraries were constructed with
ScriptSeq Complete Gold kits (Epicentre Biosciences) and were se-
quenced on an Illumina HiSeq instrument. Reads from each strain were
mapped to the corresponding genome assembly and RPKM (number of
mapped reads per kilobase of gene length per million total mapped reads)
values were calculated in CLC (version 7.0.4). Genes with significantly
different RPKM values were identified using the Significant Analysis for
Microarray (SAM) (24) statistical analysis component of Multiexperi-
ment Viewer (MeV version 4.9 [www.tm4.org]), where Colr and Cols
strains represented the two unpaired classes.
Complementation assay. To determine whether the mutation in crrB
was necessary to confer colistin resistance, a pUC-19-derived plasmid
containing the wild-type crrB gene as well as the upstream and down-
stream flanking sequences was introduced into UHKPC26 and UHKPC28.
To generate a plasmid vector with a zeocin marker that could be used for
selection of transformants in the MDR background of these strains, the
bla gene in the pUC19 vector was replaced with the open reading frame of
the resistance gene for zeocin. Specifically, by using the primers
Zeo_ORF_F and Zeo_ORF_R (primer sequences are shown in Table S1 in
the supplemental material), a 412-bp PCR fragment representing the
open reading frame (ORF) of the zeocin resistance gene was amplified
from a pAF6-derived plasmid (25). A vector fragment ending with the bla
promoter and terminator, but not extending into the bla ORF, was am-
plified as a 1,857-bp fragment from pUC19 using the primers Zeo-
pUC19_F and Zeo-pUC19_R. These fragments were purified using a PCR
clean-up kit (ZymoResearch) and combined using Gibson assembly (26).
The assembly product was used for transformation of NEB5 Escherichia
coli cells (New England BioLabs). Plasmids were prepared from the trans-
formants using a miniprep kit (Qiagen) and confirmed using restriction
analysis with SmaI (New England BioLabs).
To clone a fragment containing the crrB gene into the zeocin plasmid,
a 2,125-bp fragment was amplified from the genomic DNA sample of the
Cols strain UHKPC27. The crrB locus is wild type in this strain. This
amplification was first performed using Q5 polymerase and the primers
MW_F_5Phos and MW_R. The amplified fragment was purified using a
PCR purification kit (ZymoResearch) and further amplified using Prime-
STAR MAX polymerase (Clontech) and the primers MW_F and MW_R.
The amplified fragment included the crrAB ORFs and the 5= and 3=
flanking sequences. The zeocin vector was amplified using PrimeSTAR
Max polymerase and the primers pUC19_MW_GA_F and pUC19_
MW_GA_R. The amplified vector and insert fragments were purified
using a PCR purification kit and used in Gibson assembly. The assem-
bly mixture was used to transform NEB5 cells. Plasmids were purified
from the transformants and confirmed using restriction analysis with
HinfI and Sanger sequencing.
Electroporation of UHKPC26 and UHKPC28 was conducted as de-
scribed previously (27) except that 1 g of DNA was introduced into the
transformation mixture and cells were recovered in 500 l low-salt LB
broth. The transformed cells were selected on an agar plate containing
low-salt LB broth and 1,250 g/ml zeocin. The presence of this plasmid in
the colonies was confirmed using PCR with the primers Jct_Up_F and
Jct_Up_R, where the amplification of the product in this PCR required the
junction between the crrA upstream sequence and the vector to be present.
A broth microdilution assay was used to determine the MIC of
UHKPC26 and UHKPC28 strains carrying the empty vector or the vector
with the crrAB genes. Overnight cultures of UHKPC26 and UHKPC28
grown in cation-adjusted Mueller-Hinton broth (MHB) plus 1,250 g/ml
zeocin were washed, resuspended in MHB broth, and inoculated into
FIG 1 Model of Colr mechanisms. (A) Diagram of genes involved in colistin resistance based on published summaries from Gram-negative bacteria. (B) Model
of newly identified proteins and potential interactions with previously described pathways of Colr. (C) Genome segment comprising differentially expressed
genes, including the mutated histidine kinase gene in UHKPC26 and UHKPC28.
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MHB with a series of colistin concentrations. The Cols strain UHKPC27
was used as a control.
Nucleotide sequence accession numbers. Sequence reads are avail-
able from the Short Read Archive at NCBI under accession numbers
SRR896011, SRR900124 to SRR900127, SRR900132 to SRR900135,
SRR900138 to SRR900144, SRR900151 to SRR900158, SRR900160 to
SRR900169, SRR900178 to SRR900184, SRR900187 to SRR900191,
SRR900193, SRR900198, SRR900199, SRR900202 to SRR900208, and
SRR921382.
RESULTS
Genomic characterization. Nine independent clinical strains rep-
resenting three MLST sequence types (15, 234, and 258) were
previously sequenced as part of a survey of K. pneumoniae strains
in Midwestern U.S. hospitals (17) (Table 1). The most common
mechanism of Colr involved mgrB alteration, a previously identi-
fied Colr mechanism in K. pneumoniae (6, 28) (Table 1). MgrB is a
negative regulator of PhoQ, and inactivation leads to overexpres-
sion of phoPQ (9). Six strains had independent mutations of mgrB.
Four strains experienced mgrB disruption mediated by different
classes of insertion sequence (IS) families inserted at different po-
sitions in the mgrB gene. The MgrB amino acid substitution in
UHKPC179 (C28Y) occurred at a cysteine residue previously
identified as involved in a key disulfide bond in MgrB (29); thus,
the substitution of a tyrosine here likely interferes with its ability to
repress PhoQ. Genome analysis indicated that an 863-bp deletion
resulted in loss of the entire mgrB gene and an adjacent ORF from
UHKPC45. Two of these strains (UHKPC52 and UHKPC179)
had a matched Cols isolate (UHKPC27 and UHKPC57, respec-
tively) from the same patient obtained before the initiation of
colistin treatment. In each case, the mgrB gene was intact in the
parental isolates and disrupted in the Colr isolate.
A second resistance mechanism was identified as a mutation in
the phoQ gene in DMC1316. The PhoQ substitution (D434N) in
the cytoplasmic GHKL domain (ATP-lid loop) in DMC1316 is
likely critical for phosphate transfer to PhoP (30).
Strains UHKPC26 and UHKPC28 did not have any mutations
in known colistin resistance pathways, but each strain possessed
an independent mutation in the histidine kinase component of a
previously uncharacterized two-component regulatory system,
which we designate CrrAB to signify colistin resistance regulation.
In each case, the “wild-type” allele is observed in Cols strains of
ST258 (e.g., locus H239_3061 from strain UHKPC45) (Table 1).
This histidine kinase gene (crrB) and an adjacent response regula-
tor (crrA) are present in all K. pneumoniae ST258 strains with the
exception of UHKPC06, where an insertion sequence (IS) event
resulted in the deletion of the region, and in many other K. pneu-
moniae strain types (Fig. 2A). It appears that all K. pneumoniae
strains have either the crr genes or an IS-mediated deletion or
substitution of the region. The crrAB genes and the two flanking
genes (Fig. 1C) do not have clear orthologs in E. coli or Salmonella,
but orthologs of these genes are present several Enterobacter ge-
nomes but in a different genomic context than in K. pneumoniae.
Because no matched Cols parental strains were available for
UHKPC26 or UHKPC28, we considered whether other variants in
these strains might be involved in the Colr phenotype by identify-
ing SNVs present in these strains relative to closely related Cols
strains. The only shared nonsynonymous mutation in the two
strains was in MenB (A244T), a naphthoate synthase protein that is
part of the menaquinone biosynthesis pathway. Strain UHKPC28
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FIG 2 Comparative analyses of the crrAB region. (A) Presence of crrAB plus upstream (conserved hypothetical membrane protein ORF) and downstream
(glycosyltransferase-like ORF) region among K. pneumoniae strains shown with a genome-wide SNV-based phylogeny constructed using kSNP output. Shared
circle color indicates shared genome content and organization; gray squares indicate the presence of a shared ISKpn26 insertion upstream of the conserved
hypothetical membrane protein H239_3059. (B) Maximum-likelihood tree of protein sequence alignment of CrrB (353 amino acids) in publicly available K.
pneumoniae genomes.
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lator component of RstAB, and a mutation in a transmembrane
domain of WecA (G134A), which is involved in cell envelope
synthesis. The complete list of sequence differences between
UHKPC24, UHKPC26, and UHKPC28 genomes and the refer-
ence genome HS11286 are given in Table S2 in the supplemental
material. None of these candidates were deemed to be stronger
candidates as the Colr mutation than the crrB mutations.
Transcriptome characterization. Two primary patterns of
changes in gene expression were observed in Colr strains relative
to Cols strains (Table 2). Common to both patterns was increased
expression of the pmrHFIJKLM operon relative to Cols strains.
This operon encodes genes responsible for the biosynthesis of
Ara4N and modification of the lipid A component of LPS with this
moiety. The six strains with mgrB modifications and the one phoQ
mutant strain shared a pattern characterized by elevated phoPQ
expression relative to Cols strains with no difference in pmrCAB
transcript levels. The mutational spectrum in mgrB suggests loss-
of-function mutations in this negative regulator of phoPQ, and
each strain showed higher phoPQ expression levels than Cols
strains from the collection. Of these strains, all but UHKPC52 also
exhibited significantly elevated transcript levels for pmrD.
In UHKPC26 and UHKPC28, the two strains with mutations
in crrB, a distinct transcriptional pattern was observed, character-
ized by elevated transcription of pmrCAB, with no difference in
phoPQ RPKM values compared to Cols strains. The sequences of
the pmrCAB locus and flanking regions in these strains were iden-
tical to those in other ST258 strains. Expression levels were higher
in UHKPC26 and UHKPC28 for crrB, a gene encoding an adjacent
conserved hypothetical membrane protein, and a gene encoding
an adjacent putative glycosyltransferase than in other Colr and
Cols strains (Table 2 and Fig. 1C). In UHKPC26, the mutation is in
the HAMP domain of the histidine kinase. In contrast, the histi-
dine kinase mutation in UHKPC28 affects the predicted signal
peptide domain, and transcript levels of the response regulator
crrA were unaffected. Neither rstA nor wecA, two other genes with
sequence variants in UHKPC28, had altered expression in
UHKPC28 relative to Cols strains.
Other components of the PhoPQ regulon, such as slyB (encod-
ing an outer membrane lipoprotein) and mgtA (encoding a mag-
nesium-importing ATPase), were upregulated in all Colr strains
(31–33), but pagP (encoding an outer membrane protein that
adds a palmitate chain to lipid A), lpxO (encoding a dioxygenase
that modifies lipid A) (34, 35), and ybjG (encoding a putative
undecaprenyl pyrophosphate phosphatase) (36) were upregu-
TABLE 2 RPKM values for differentially expressed genes or those that have been previously associated with PhoPQ or PmrAB regulons in other
organisms
a A representative locus ID for each gene from the K. pneumoniae UHKPC45 genome sequence (ARVO01000000) is given. Locus IDs in orange are predicted to be part of the
PhoPQ regulon.
b Means and standard deviations are given for all Cols strains (n  45). RPKM values in green are significantly different (P  0.05) and 2-fold higher in Colr strains than the mean
value in Cols strains. Yellow indicates significantly different (P  0.05) but 2-fold-different RPKM values. NA, gene not present in the genome.
c SD, standard deviation.
Wright et al.
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lated only in the mgrB and phoQ mutant strains. Other genes with
altered transcription include those associated with cation trans-
port, membrane integrity, and the macAB efflux transporters (Ta-
ble 2). Expression of pmrD was elevated in some strains yet was not
correlated with expression of pmrCAB under these experimental
conditions for strains with mgrB or phoQ alterations. RPKM val-
ues for mgrB for strains with full-length sequences did not vary
between Colr and Cols strains, indicating that the phoQ mutation
in DMC1316 and related increased expression did not activate the
feedback inhibition mediated by MgrB. No correlation was ob-
served between the colistin MIC and the genetic mechanism of
resistance: the MIC of strains with mgrB mutations ranged from 4
to 32 g/ml. This could indicate that variation in additional genes,
including genes in the phoPQ regulon, may modulate the resis-
tance phenotype.
Confirmation of the role of crrB in colistin resistance. To
confirm that the crrB mutations in UHKPC26 and UHKP28 were
necessary to confer colistin resistance, we cloned the wild-type
crrAB genes from UHKPC27 into a pUC19-derived vector carry-
ing a zeocin resistance marker and introduced this plasmid into
the Colr strains. The UHKPC27 sequence is identical to that in
UHKCP26 and UHKPC28 except for the hypothesized Colr-associ-
ated mutations. Colistin susceptibility was restored to UHKPC26 and
UHKPC28 cells carrying the crrAB plasmid but not to cells with
the vector alone (Table 3).
DISCUSSION
Two distinct transcription profiles were observed; common to
both was increased expression of the Ara4N pathway. Previous
studies have shown linkage between Colr and pmrCAB expression
(6, 12) and cross talk between pmrAB and phoPQ (37). The strains
reported here demonstrate upregulation of either the pmrAB or
phoPQ genes, but not both in the same Colr strain. The identifica-
tion of the crr genes as additional regulators of colistin resistance
expands the number of known genes that modulate this pheno-
type and highlights multifaceted ways that cells respond to anti-
microbial peptide challenge.
The CrrAB proteins are not orthologs of other TCRS linked to
PhoPQ or cell envelope stress response, such as RcsAB (38), RstAB
(32), EvgAS (36), CpxAR (39), and BaeSR (40). Comparative
analyses indicate that the crrAB region is variably present in K.
pneumoniae, although it is present in nearly all ST258 strains
(green circles in Fig. 2) and is found in other Klebsiella and Entero-
bacter species, albeit in different genomic contexts. In Enterobacter
sp. strain SST3, a plant endophyte, the region is adjacent to the sap
(sensitivity to antimicrobial peptides) operon (41). In K. pneu-
moniae genomes without these genes, either a lipoprotein of un-
known function is present at this genomic location, or a phage-
related integrase and transposase are present. The GC content of
this region is approximately 40%, much lower than the average
GC content of 50% for the K. pneumoniae chromosome, sug-
gesting that it was laterally acquired. Genomic analysis also sug-
gests that IS events are reshaping the region. ST258a strains de-
scribed in reference 17 all have the same ISKpn26 insertion
upstream of the conserved hypothetical protein (H239_3062),
which also resulted in the deletion of 468 bp and truncation of an
adjacent ABC transporter (H239_3063). Interestingly, eight
ST258b strains described in reference 42 carried the same IS,
ISKpn26, inserted at the same chromosomal position, suggesting a
recombination event at this location. A phylogeny of CrrB is
largely congruent with the SNV-based whole-genome phylogeny
(Fig. 2B).
Both UHKPC26 and UHKPC28 had significantly elevated
expression of an adjacent conserved hypothetical protein
(H239_3059), a putative glycosyltransferase with a TupA-like
ATP grasp domain (PF14305), which is predicted to be involved in
surface polysaccharide biosynthesis, and an adjacent uncharacter-
ized conserved membrane protein (H239_3062). These strains
also had elevated expression of both the pmrH and pmrCAB oper-
ons, which encode the Ara4N and pETN pathways of LPS modi-
fication. Our working hypothesis is that CrrAB induces expression
of the glycosyltransferase-like protein which transfers an as-yet-
unidentified sugar to lipid A phosphate in a manner analogous to
PmrC (Fig. 1B). The basis for the upregulation of pmrCAB has not
been established. It is possible that CrrB, the novel TCRS histidine
kinase, directly phosphorylates PmrA or that a yet-to-be-identi-
fied connector protein, perhaps the conserved hypothetical mem-
brane protein (H239_3062), facilitates feedback between the two
systems.
UHKPC26 and UHKPC28 do carry other single-nucleotide
variants (SNVs) compared with Cols strains (see Table S1 in the
supplemental material). RstA has been shown to be induced by
PhoPQ in other Gram-negative pathogens (32, 43); however, the
variant seen in UHKPC28 is unlikely to have contributed to the
Colr phenotype as neither rstAB nor phoPQ expression was altered
in UHKPC28. Furthermore, the UHKPC26 sequence was identi-
cal to Cols strains across this region, and the expression profiles are
similar between the two strains. An additional variant was ob-
served in a transmembrane region of WecA, which is involved in
O-antigen biosynthesis, in strain UHKPC28 but is not predicted
to be a key residue (44–46). However, the UHKPC26 wecA RPKM
value was significantly lower than that in Cols strains even though
there was no mutation in this gene. An examination of a potential
role for WecA in LPS modification and a better characterization of
what regulates its expression is needed to better understand any
potential role in Colr.
Other transcription changes common to Colr strains included
increased expression of cation transporters and other efflux
pumps, which could be a response to altered membrane charge
and difficulty in transporting cations through a LPS layer with a
more neutral charge. Other genomic changes include the loss of
blaKPC plasmids in UHKPC52 and UHKPC179 which were pres-
ent in a closely related strain in the case of UHKPC52, or isogenic
paired strain UHKPC57 in the case of UHKPC179. The loss of
these plasmids suggests that there may be a fitness cost associated
with acquiring colistin resistance that is partially mitigated by the
plasmid loss, and this should be more rigorously explored with
formalized fitness comparisons.




UHKPC26  vector 16
UHKPC26 crrAB 0.5
UHKPC28 16
UHKPC28  vector 16
UHKPC28 crrAB 0.5
a Determined by broth microdilution in cation-adjusted Mueller-Hinton broth.
Transcriptome of Colistin-Resistant K. pneumoniae
January 2015 Volume 59 Number 1 aac.asm.org 541Antimicrobial Agents and Chemotherapy
This study identified transcriptional changes of Colr strains
during growth without colistin. Further experiments to examine
how colistin exposure alters gene expression may provide addi-
tional insight into the resistance mechanism(s). Analysis of LPS
and lipid A structures may identify novel modifications in
UHKPC26 and UHKPC28. In addition, formal analysis of the
fitness cost of resistance along with follow-up experiments to ex-
amine how the observed LPS modifications alter K. pneumoniae
host interaction is important to understand the impact of colistin
resistance on virulence.
Conclusions. The combination of genomic and transcrip-
tomic analysis revealed three genetic mechanisms conferring
colistin resistance with distinct global gene expression profiles de-
pending on the genetic mechanism. Interestingly, we found that
each strain possessed unique mutations predicted to confer colis-
tin resistance. Although the sample collection was not designed to
be comprehensive or represent a formal epidemiological study,
the absence of repeat observations of specific mutations suggests
that independently derived Colr strains of K. pneumoniae may be
more common than patient-to-patient spread of resistant strains.
Moreover, the constellation of changes that can lead to a “final
common phenotype” will challenge the future development of
cationic antimicrobial peptides and molecular diagnostics, as tar-
gets may vary across strains. The fact that mutations were found in
genes without E. coli orthologs highlights the importance of study-
ing colistin resistance across the range of clinically significant
pathogens.
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